APA (7th ed.) Citation

Ford, J., Lawson, M., Fowler, D., Maruyama, N., Mito, S., Tomiyasu, K., . . . Kastelein, J. J. P. (2014). Tolerability, pharmacokinetics and pharmacodynamics of TA‐8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. British journal of clinical pharmacology, 78(3), 498-508. https://doi.org/10.1111/bcp.12380

Chicago Style (17th ed.) Citation

Ford, John, et al. "Tolerability, Pharmacokinetics and Pharmacodynamics of TA‐8995, a Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects." British Journal of Clinical Pharmacology 78, no. 3 (2014): 498-508. https://doi.org/10.1111/bcp.12380.

MLA (9th ed.) Citation

Ford, John, et al. "Tolerability, Pharmacokinetics and Pharmacodynamics of TA‐8995, a Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects." British Journal of Clinical Pharmacology, vol. 78, no. 3, 2014, pp. 498-508, https://doi.org/10.1111/bcp.12380.